Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Marijuana and Nabiximols



Research Papers that Mention the Interaction

The combination of Sativex and MET/CBT reduced the amount of cannabis use and progressively reduced craving and withdrawal scores.
Journal of addiction medicine  •  2016  |  View Paper
Researchers reported that patients who were treated for 12 weeks with nabiximols significantly reduced the number of days on which they used cannabis (18.6 days less compared to placebo users; 95% CI: 3.5-33.7).
Nederlands tijdschrift voor geneeskunde  •  2020  |  View Paper
RESULTS A … na iximols group us nabis on 6.8 fewer days in the previous 28 days at week 12 (end of treatment) than the placebo group (p = 0.002, … the previous 28 days at the week-24 follow-up than the placebo group (p = 0.006, CI: 1.4,12.1).
Drug and alcohol dependence  •  2020  |  View Paper
Cannabis use was reduced in the nabiximols (70.5%) and placebo groups (42.6%).
Nabiximols reduced cannabis craving but no significant differences between the nabiximols and placebo groups were observed on withdrawal scores.
We previously showed that nabiximols (27 mg/ml Δ9-tetrahydrocannabinol (THC)/ 25 mg/ml cannabidiol (CBD), Sativex®) can decrease cannabis withdrawal symptoms.
PloS one  •  2018  |  View Paper
BackgroundThe cannabis extract nabiximols (Sativex®) effectively supresses withdrawal symptoms and cravings in treatment resistant cannabis dependent individuals, who have high relapse rates following conventional withdrawal treatments.
BMC Psychiatry  •  2018  |  View Paper
CONCLUSIONS AND RELEVANCE In a treatment-seeking cohort, na iximols at tenuated can nabis wi thdrawal symptoms and improved patient retention in treatment.
RESULTS Na iximols tr eatment significantly reduced the overall severity of can nabis wi thdrawal relative to placebo (F8,377.97 = 2.39; P = .01), including effects on withdrawal-related irritability, depression, and cannabis cravings.
JAMA psychiatry  •  2014  |  View Paper
Sativex was shown to have low abuse potential when administered in supratherapeutic doses to recreational marijuana users [6]; it is expected that the abuse potential would be even less when doses are distributed evenly throughout the day [6].
Expert review of neurotherapeutics  •  2013  |  View Paper